A complete ten-stage journey, with GiiAssay leading the first three stages and flexible support for later stages, either through your in-house team or our industry-expert partners.
Stage 1: Antibody Screening
Timeline: 10 weeks
Description: “Identifying optimal antibody candidates tailored to your target marker.”
Stage 2: Assay Feasibility
Timeline: 6 months
Description: “Assessing the assay’s compatibility with Gii technology to ensure performance.”
Stage 3: Assay Development and Optimisation
Timeline: 9-12 months
Description: “Refining and optimising the assay for reliable integration into your device.”